Helen Bayliss
About Helen Bayliss
Helen Bayliss is the Brand Lead for the UK and Ireland at Aimmune Therapeutics, where she has worked since 2021. She has extensive experience in pharmaceutical marketing across various therapeutic areas and has held positions at several prominent companies, including Boehringer Ingelheim, Novo Nordisk, and Pfizer.
Current Role at Aimmune Therapeutics
Helen Bayliss serves as the Brand Lead for the UK and Ireland at Aimmune Therapeutics, a position she has held since 2021. In this role, she is responsible for developing and implementing brand strategies to enhance the company's presence in the region. Her work focuses on ensuring that marketing initiatives align with the needs of patients and healthcare providers.
Previous Experience in Pharmaceutical Marketing
Helen Bayliss has a diverse background in pharmaceutical marketing, having held various roles across multiple companies. She worked at Boehringer Ingelheim as a Product Manager from 2005 to 2007 and later as a Brand Intelligence Manager from 2003 to 2005. Her experience also includes positions at Pfizer European Marketing as a Regional Brand Manager and at Novo Nordisk as Brand Lead for Insulin & Devices from 2019 to 2021.
Education and Academic Background
Helen Bayliss studied at the University of Warwick from 1994 to 1998, where she completed her degree over a four-year period. Her education has provided her with a strong foundation for her career in pharmaceutical marketing and brand management.
Expertise in Therapeutic Areas
Helen has extensive expertise in multiple therapeutic areas, including oncology, cardiology, psychiatry, neurology, and urology. This broad knowledge base allows her to develop effective marketing strategies that address the specific needs of different patient populations.
Skills and Professional Attributes
Helen Bayliss is experienced in working across multi-cultural environments, showcasing her adaptability and communication skills. She emphasizes patient-centric approaches in her marketing strategies and demonstrates resourcefulness by delivering results with limited resources. Recently returning from maternity leave, she balances her personal and professional commitments.